Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - TOTAL CURRENT LIABILITIES
Total Current Liabilities EXEL - Exelixis, Inc.
404 M
LAST VALUE
11.57%
2 YEAR CAGR
23.12%
5 YEAR CAGR
8.92%
10 YEAR CAGR